CCIWA Call (888) 217-1376 24/7 confidential

Medical Detox in California

Composite analysis

Treatment Access Pressure Index

Moderate pressure49Rank 27 of 52

California falls in the lower half for treatment access pressure. Statewide capacity is closer to the median, but rural counties may still be underserved.

Mental health HPSA score (weighted)
17.59
0–25 scale. Higher means greater federally-designated shortage. 122,894,636 residents live inside designated mental health HPSAs.
Source: HRSA Data Warehouse
Frequent mental distress
16.7%
Population-weighted share of adults reporting 14+ days of poor mental health in the last month.
Source: CDC PLACES (BRFSS 2022)
Unemployment rate
5.4%
Seasonally adjusted state unemployment, used as a stress proxy. Latest period: M02 2026.
Source: BLS Local Area Unemployment Statistics
Verified treatment density
12.71
Methadone OTPs plus buprenorphine prescribers per 100,000 residents. Higher density lowers pressure. (140 OTPs, 4,814 bupren providers.)
Source: SAMHSA + CMS NPPES (CCIWA dataset)

TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.

Detox alone has a dismal track record for opioid use disorder. The reason is biological, not motivational. Once tolerance drops, relapse risk during the first two weeks after discharge is the highest of any window in the disease. California runs its Medicaid program with methadone, buprenorphine, and naltrexone covered, which means the state has the medication infrastructure to bridge from detox into real treatment if a program chooses to use it.

What changes by state

FactorCalifornia
Medicaid covers methadoneYes
Medicaid covers buprenorphineYes
Medicaid covers residential SUDYes
1115 SUD waiverActive
IMD exclusion statusWaived – IMD exclusion waived under DMC-ODS for SUD residential treatment; 30-day statewide average LOS (90-day max under original 2015 guidance); expanded under CalAIM
Drug overdose deaths (2023)11,378

What to ask any California detox program

The five questions on our detox overview page apply everywhere, but two of them tighten up here based on what California Medicaid actually pays for. If buprenorphine is not started before discharge, that is a major clinical red flag. If a program tells you methadone is "not allowed" during detox, that is incorrect under federal rule and worth a second opinion.

If you have already detoxed

The single highest-leverage move after detox is a same-week MOUD appointment. California OTPs can induct same day or next day in most cases. Buprenorphine prescribers in California can often do an in-office induction within 48 hours.

For the full coverage breakdown including prior authorization rules and continuity of care obligations, see the California insurance guides are coming soon.